Antara Capital LP

In its 13F for Q4 2025 (holdings as of December 31, 2025, filed February 17, 2026), Antara Capital LP reported 1 stock position worth $27 thousand. Its top holding was Aspire Biopharma at 100.0% of the portfolio. Compared with Q3 2025, it sold out of 1. The biggest sale was an exit from Currenc (CURR).

Most Recent 13F
Q4 2025
Location
New York, NY
CIK
0001750183
Portfolio Value
$27K (Q4 2025)
SEC Filing
0001172661-26-001155 ↗ filed Feb 17, 2026

Holdings Value

0$20.0M$40.0M$60.0M Q1 2024: $40.5M Q1 2024 Q2 2024: $59.6M Q2 2024 Q3 2024: $18.1M Q3 2024 Q4 2024: $23.1M Q4 2024 Q1 2025: $27K Q1 2025 Q2 2025: $1.1M Q2 2025 Q3 2025: $484K Q3 2025 Q4 2025: $27K $27K Q4 2025

Holdings 1 stocks · $27K
ASPIRE BIOPHARMA HLDGS INC 100.00% 202,897 $27K No change
Other holdings (1): bonds, preferreds, convertibles and warrants · $3K (not counted above)
SecurityClassShares / PrincipalValueChange
ASBPW Aspire Biopharma Holdin-CW27 *W EXP 02/14/203 207,693$3KNo change

Total filed on the 13F, all lines: $30K.

Portfolio Sells Q3 2025 → Q4 2025
CURR Currenc Group Inc. Sold out 0.00% −91.36

Portfolio Buys Q3 2025 → Q4 2025
None this quarter.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q4 2025 1$27KASPIRE BIOPHARMA HLDGS INC
Q3 2025 2$484KCURR, ASPIRE BIOPHARMA HLDGS INC
Q2 2025 2$1.1MCURR, RZLV
Q1 2025 2$27KTHCH, LONGEVITY HEALTH HLDGS INC
Q4 2024 7$23.1MBRSL, BUR, NKLAQ, INVZ, MANU
Q3 2024 9$18.1MEDR, INVZ, CZR, BRSL, BUR
Q2 2024 10$59.6MCHPT, ACI, BRSL, BUR, KR
Q1 2024 9$40.5MSHY, CHPT, UHG, ACI, ALTERNUS CLEAN ENERGY INC